153 related articles for article (PubMed ID: 23908975)
1. Evaluation of adiposity-related biomarkers as metabolic syndrome indicators.
Bae YJ; Kim SH; Chung JH; Song SW; Kim KS; Kim MK; Kwon O; Choi MS; Sung MK
Clin Nutr Res; 2013 Jul; 2(2):91-9. PubMed ID: 23908975
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs.
Abu-Farha M; Behbehani K; Elkum N
Cardiovasc Diabetol; 2014 Apr; 13():76. PubMed ID: 24716628
[TBL] [Abstract][Full Text] [Related]
3. Adipokines, inflammatory mediators, and insulin-resistance parameters may not be good markers of metabolic syndrome after liver transplant.
Anastácio LR; de Oliveira MC; Diniz KG; Ferreira AM; Lima AS; Correia MI; Vilela EG
Nutrition; 2016 Sep; 32(9):921-7. PubMed ID: 27189907
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Long Non-coding RNA LncRNA-FA2H-2 With Inflammatory Markers in the Peripheral Blood of Patients With Coronary Heart Disease.
Guo F; Sha Y; Hu B; Li G
Front Cardiovasc Med; 2021; 8():682959. PubMed ID: 34235188
[No Abstract] [Full Text] [Related]
5. Cardiometabolic risk factors in preschool children with abdominal obesity from Medellín, Colombia.
Marín-Echeverri C; Aristizábal JC; Gallego-Lopera N; Santa-Ramírez HA; Hoyos-Gómez M; Ruiz-Pineda AM; Arias AA; Barona-Acevedo J
J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1179-1189. PubMed ID: 30367807
[TBL] [Abstract][Full Text] [Related]
6. Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome.
Beumer W; Drexhage RC; De Wit H; Versnel MA; Drexhage HA; Cohen D
Psychoneuroendocrinology; 2012 Dec; 37(12):1901-11. PubMed ID: 22541717
[TBL] [Abstract][Full Text] [Related]
7. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
[TBL] [Abstract][Full Text] [Related]
8. The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis.
Kaur S; Zilmer K; Leping V; Zilmer M
J Eur Acad Dermatol Venereol; 2011 Nov; 25(11):1328-33. PubMed ID: 21349112
[TBL] [Abstract][Full Text] [Related]
9. Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia.
Mednova IA; Boiko AS; Kornetova EG; Parshukova DA; Semke AV; Bokhan NA; Loonen AJM; Ivanova SA
Metabolites; 2020 Oct; 10(10):. PubMed ID: 33066473
[TBL] [Abstract][Full Text] [Related]
10. A novel protein glycan biomarker and LCAT activity in metabolic syndrome.
Gruppen EG; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
Eur J Clin Invest; 2015 Aug; 45(8):850-9. PubMed ID: 26081900
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Power of Circulatory Metabolic Biomarkers as Metabolic Syndrome Risk Predictors in Community-Dwelling Older Adults in Northwest of England (A Feasibility Study).
Hassannejad R; Sharrouf H; Haghighatdoost F; Kirk B; Amirabdollahian F
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34209146
[TBL] [Abstract][Full Text] [Related]
12. Beyond the Scale: Investigating Adiponectin, ICAM-1, and VCAM-1 as Metabolic Markers in Obese Adolescents with Metabolic Syndrome.
Widjaja NA; Caesar LA; Nova S; Ardianah E
J Obes; 2023; 2023():4574042. PubMed ID: 37822716
[TBL] [Abstract][Full Text] [Related]
13. Follow-ups of metabolic, inflammatory and oxidative stress markers, and brachial-ankle pulse wave velocity in middle-aged subjects without metabolic syndrome.
Kim OY; Paik JK; Lee JY; Lee SH; Lee JH
Clin Exp Hypertens; 2013; 35(5):382-8. PubMed ID: 23148723
[TBL] [Abstract][Full Text] [Related]
14. Association of Oxytocin with Glucose Intolerance and Inflammation Biomarkers in Metabolic Syndrome Patients with and without Prediabetes.
Akour A; Kasabri V; Bulatova N; Al Muhaissen S; Naffa R; Fahmawi H; Momani M; Zayed A; Bustanji Y
Rev Diabet Stud; 2018; 14(4):364-371. PubMed ID: 29590229
[TBL] [Abstract][Full Text] [Related]
15. Independent and additive effects of cytokine patterns and the metabolic syndrome on arterial aging in the SardiNIA Study.
Scuteri A; Orru M; Morrell C; Piras MG; Taub D; Schlessinger D; Uda M; Lakatta EG
Atherosclerosis; 2011 Apr; 215(2):459-64. PubMed ID: 21241986
[TBL] [Abstract][Full Text] [Related]
16. The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome.
McAlister KL; Fisher KL; Dumont-Driscoll MC; Rubin DA
J Pediatr Endocrinol Metab; 2018 Aug; 31(8):837-845. PubMed ID: 29975666
[TBL] [Abstract][Full Text] [Related]
17. Chemerin Ratios to HDL-cholesterol and Adiponectin as Biomarkers of Metabolic Syndrome.
Shafer-Eggleton J; Adams-Huet B; Jialal I
Endocr Res; 2020 Nov; 45(4):241-245. PubMed ID: 32835545
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil and monocyte ratios to high-density lipoprotein-cholesterol and adiponectin as biomarkers of nascent metabolic syndrome.
Jialal I; Jialal G; Adams-Huet B; Ramakrishnan N
Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167929
[TBL] [Abstract][Full Text] [Related]
19. Adipokines and endothelial dysfunction in obesity WHO°III.
Bachmayer C; Kemmer A; Ehrmann N; Hasenberg T; Lammert A; Hammes HP
Microvasc Res; 2013 Sep; 89():129-33. PubMed ID: 23648313
[TBL] [Abstract][Full Text] [Related]
20. Association of selected adipokines with metabolic syndrome and cardio-metabolic risk factors in young males.
Ouerghi N; Ben Fradj MK; Talbi E; Bezrati I; Feki M; Bouassida A
Cytokine; 2020 Sep; 133():155170. PubMed ID: 32554156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
